Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62 Sell
3
-28
-90% -$660 ﹤0.01% 674
2026
Q1
$705 Sell
31
-60
-66% -$1.42K ﹤0.01% 561
2025
Q4
$2.42K Buy
+91
New +$2.69K ﹤0.01% 350
2025
Q1
Sell
-201
Closed -$8.82K 410
2024
Q4
$8.82K Sell
201
-62
-24% -$2.72K ﹤0.01% 360
2024
Q3
$11.3K Buy
+263
New +$11.7K ﹤0.01% 224

Other funds holding ENOV

Elequin Capital's ENOV Position: Q2 2026 in Review

Elequin Capital reduced its Enovis (ENOV) stake by 90% in Q2 2026, selling an estimated $660 and leaving 3 shares worth $62. The position accounts for ﹤0.01% of the portfolio, ranked #674.

Elequin Capital first reported a position in ENOV in Q3 2024 and has held it in 5 quarters since. The position peaked at $11.3K in Q3 2024. 254 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Elequin Capital held 3 shares of Enovis worth $62 as of Q2 2026.
  • Elequin Capital sold 28 Enovis shares in Q2 2026, an estimated $660.
  • Enovis made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #674 holding.
  • Elequin Capital first reported a position in Enovis in Q3 2024 and has held it in 5 quarters since.
  • Elequin Capital's Enovis position peaked at $11.3K in Q3 2024.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.